Clinical effect and influence on T cell subsets of Yinzhihuang oral solution combined Bifico in patients with neonatal jaundice
-
摘要: 目的 探讨茵栀黄口服液联合培菲康对新生儿黄疸的疗效及对患儿T细胞亚群的影响。 方法 选取2016年2-7月台州医院新生儿科收治的新生儿黄疸患儿200例,采用随机数字表法分为对照组和观察组。对照组100例,其中男58例,女42例,胎龄36~42周,平均胎龄(39.1±1.7)周,采用蓝光等常规治疗;观察组100例,其中男59例,女41例,胎龄36~42周,平均胎龄(38.9±1.8)周,在对照组常规治疗的基础上,加用茵栀黄口服液和培菲康。比较2组治疗效果,治疗前、治疗7 d后T细胞亚群差异,以及不良反应情况。 结果 观察组患儿治疗总有效率为95.00%,对照组患儿治疗总有效率为80.00%,观察组治疗总有效率明显高于对照组(χ2=10.286,P<0.05);观察组光疗时间、黄疸消退时间、住院时间均明显少于对照组(t值分别为7.982、7.698、5.580,均P<0.05),日均胆红素下降值明显高于对照组(t=7.491,P<0.05);治疗7 d后,2组新生儿CD3+、CD4+、CD4+/CD8+均较治疗前显著升高(观察组t值分别为7.929、16.561、8.433,对照组t值分别为1.978、6.015、3.409,均P<0.05),且观察组升高更显著(t值分别为4.975、9.835、5.085,均P<0.05);观察组不良反应发生率为5%,对照组不良反应发生率为9%,2组不良反应发生率差异无统计学意义(χ2=1.229,P>0.05)。 结论 茵栀黄口服液联合培菲康对新生儿黄疸的疗效显著,可明显改善患儿T细胞亚群状态,增强免疫功能。Abstract: Objective To investigate the clinical effect and influence on T cell subsets of Yinzhihuang oral solution combined Bifico in patients with neonatal jaundice. Methods A total of 200 patients with neonatal jaundice in our hospital from February,2016 to July,2016 were randomly divided into control group (100 cases) and observation group (100 cases).The patients of the control group,including 58 male and 42 female,gestational age 36-42 weeks,average gestational age (39.1±1.7) weeks,received conventional treatment (Blue-ray et al.);The patients of the observation group,including 59 male and 41 female,gestational age 36-42 weeks,average gestational age (39.1±1.7) weeks,received conventional treatment and additional Yinzhihuang oral solution combined Bifico.The clinical effect and influence on T cell subsets were compared before and after the treatment between the two groups. Results The total effective rate of the observation group was 95.00%,of the control group was 80.00%,the difference between the two groups was significant (χ2=10.286,P<0.05);The time of phototherapy,jaundice and hospitalization of the observation group was significantly lower than those in the control group (t=7.982,7.698,5.580,P<0.05),and daily average bilirubin decline value was significantly higher than that in the control group (t=7.491,P<0.05);Compared with the levels before the treatment,the levels of CD3+,CD4+,CD4+/CD8+ increased significantly at 7 d after the treatment in both groups (observation group:t=7.929,16.561,8.433,control group:t=1.978,6.015,3.409,P<0.05),and the levels of CD3+,CD4+,CD4+/CD8+ of the observation group increased more significantly at 7 d after the treatment (t=4.975,9.835,5.085,P<0.05);Incidence of adverse reactions of the observation group was 5%,and of control group was 9%,there was no significant difference between the two groups (χ2=1.229,P>0.05). Conclusion Yinzhihuang oral solution combined with Bifico has obvious clinical effect on neonatal jaundice.It can significantly improve T cell subsets status,and enhance immune function of patients with neonatal jaundice.
-
Key words:
- Neonatal jaundice /
- Yinzhihuang oral solution /
- Bifico /
- T cell subsets
点击查看大图
计量
- 文章访问数: 103
- HTML全文浏览量: 20
- PDF下载量: 0
- 被引次数: 0